Systematic

Systematic Medicine is a pre-clinical biotechnology company dedicated to addressing the root causes of aging by targeting the accumulation of somatic DNA mutations. The company is developing high-accuracy sequencing assays and robust drug discovery models to identify interventions that can slow or reverse genomic instability. Often described as seeking a "statin for the genome," Systematic Medicine aims to translate its research into therapeutic strategies that mitigate age-related decline and improve human healthspan. Based in Melbourne, Australia, the company operates as part of the Leading Technology Group (LTG) and emphasizes scientific rigor and reproducibility in its translational approach.